Home LiteratureArticle Details
PMID: 16519916 Published · ppublish English Journal Article

Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry.

Virology ·Vol. 350 ·No. 2 ·2006-07-05 ·Pages 358-69

Follis KE, York J, Nunberg JH

Abstract

The fusogenic potential of Class I viral envelope glycoproteins is activated by proteloytic cleavage of the precursor glycoprotein to generate the mature receptor-binding and transmembrane fusion subunits. Although the coronavirus (CoV) S glycoproteins share membership in this class of envelope glycoproteins, cleavage to generate the respective S1 and S2 subunits appears absent in a subset of CoV species, including that responsible for the severe acute respiratory syndrome (SARS). To determine whether proteolytic cleavage of the S glycoprotein might be important for the newly emerged SARS-CoV, we introduced a furin recognition site at single basic residues within the putative S1-S2 junctional region. We show that furin cleavage at the modified R667 position generates discrete S1 and S2 subunits and potentiates membrane fusion activity. This effect on the cell-cell fusion activity by the S glycoprotein is not, however, reflected in the infectivity of pseudotyped lentiviruses bearing the cleaved glycoprotein. The lack of effect of furin cleavage on virion infectivity mirrors that observed in the normally cleaved S glycoprotein of the murine coronavirus and highlights an additional level of complexity in coronavirus entry.

MeSH Terms
Amino Acid Sequence Animals COS Cells Cell Fusion Chlorocebus aethiops Furin/metabolism Membrane Glycoproteins/chemistry,genetics,physiology Molecular Sequence Data SARS Virus/physiology Spike Glycoprotein, Coronavirus Viral Envelope Proteins/chemistry,genetics,physiology Virion/genetics,physiology
Chemicals
Membrane Glycoproteins Spike Glycoprotein, Coronavirus Viral Envelope Proteins spike glycoprotein, SARS-CoV Furin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Follis Kathryn E
Montana Biotechnology Center, Science Complex Room 221, The University of Montana, Missoula, MT 59812, USA.
York Joanne
Nunberg Jack H
References (66)
66 references, click to expand
  1. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.
    J Virol. 1999 Feb;73(2):1419-26 PMID: 9882347
  2. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6 PMID: 3095828
  3. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.
    Infect Immun. 1995 Jan;63(1):82-7 PMID: 7806387
  4. Enveloped viruses: a common mode of membrane fusion?.
    Curr Biol. 1997 Sep 1;7(9):R565-9 PMID: 9285698
  5. Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus.
    J Virol Methods. 2004 Sep 1;120(1):87-96 PMID: 15234813
  6. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.
    J Biol Chem. 2006 Feb 10;281(6):3198-203 PMID: 16339146
  7. Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent.
    J Virol. 2004 Jul;78(14):7369-78 PMID: 15220410
  8. Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion.
    Virology. 1995 Dec 20;214(2):453-63 PMID: 8553547
  9. Mechanisms of viral membrane fusion and its inhibition.
    Annu Rev Biochem. 2001;70:777-810 PMID: 11395423
  10. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.
    J Virol. 2003 Aug;77(16):8801-11 PMID: 12885899
  11. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
    J Virol. 2004 Oct;78(19):10328-35 PMID: 15367599
  12. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event.
    J Virol. 2005 Feb;79(3):1595-604 PMID: 15650185
  13. Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus.
    Mol Immunol. 2005 Jan;42(1):125-36 PMID: 15488951
  14. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.
    J Virol. 2004 Jun;78(11):5642-50 PMID: 15140961
  15. The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.
    J Neurovirol. 2002 Oct;8(5):400-10 PMID: 12402166
  16. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
    Lancet. 2003 Jul 26;362(9380):263-70 PMID: 12892955
  17. Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis.
    Trends Cell Biol. 1999 Jan;9(1):28-35 PMID: 10087614
  18. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.
    J Virol. 2004 Oct;78(19):10628-35 PMID: 15367630
  19. A novel coronavirus associated with severe acute respiratory syndrome.
    N Engl J Med. 2003 May 15;348(20):1953-66 PMID: 12690092
  20. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.
    J Virol. 2004 Sep;78(17):9007-15 PMID: 15308697
  21. Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways.
    Virology. 1997 Jun 23;233(1):1-8 PMID: 9201212
  22. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.
    Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52 PMID: 15184046
  23. Identification of a virus-specified protein in the nucleus of vaccinia virus-infected cells.
    J Gen Virol. 1980 Apr;47(2):293-9 PMID: 7365469
  24. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.
    J Mol Biol. 2003 Aug 29;331(5):991-1004 PMID: 12927536
  25. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.
    Science. 2003 Oct 10;302(5643):276-8 PMID: 12958366
  26. The signal peptide of the Junín arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex.
    J Virol. 2004 Oct;78(19):10783-92 PMID: 15367645
  27. Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.
    J Cell Biol. 1990 Dec;111(6 Pt 2):2851-9 PMID: 2269657
  28. The phylogeny of SARS coronavirus.
    Arch Virol. 2004 Mar;149(3):621-4 PMID: 14991447
  29. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
    Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):17958-63 PMID: 15604146
  30. Genetic evolution and tropism of transmissible gastroenteritis coronaviruses.
    Virology. 1992 Sep;190(1):92-105 PMID: 1326823
  31. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
    Nature. 2003 Nov 27;426(6965):450-4 PMID: 14647384
  32. Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.
    Biochem Biophys Res Commun. 2005 Jan 21;326(3):554-63 PMID: 15596135
  33. Precursor processing by kex2/furin proteases.
    Chem Rev. 2002 Dec;102(12):4525-48 PMID: 12475200
  34. The SARS-CoV S glycoprotein: expression and functional characterization.
    Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64 PMID: 14651994
  35. Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2.
    J Virol. 1993 Mar;67(3):1195-202 PMID: 8437210
  36. Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region.
    Virology. 2005 Oct 10;341(1):122-9 PMID: 16081124
  37. Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
    N Engl J Med. 2003 May 15;348(20):1967-76 PMID: 12690091
  38. Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein.
    Virology. 2005 May 10;335(2):276-85 PMID: 15840526
  39. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.
    J Virol. 2002 Jan;76(1):406-10 PMID: 11739705
  40. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Virology. 1995 Feb 1;206(2):935-44 PMID: 7531918
  41. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion.
    J Virol. 2001 Mar;75(6):2792-802 PMID: 11222703
  42. Structural basis for membrane fusion by enveloped viruses.
    Mol Membr Biol. 1999 Jan-Mar;16(1):3-9 PMID: 10332732
  43. Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment.
    Infect Immun. 1981 Mar;31(3):1214-22 PMID: 7228403
  44. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.
    Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81 PMID: 16081529
  45. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments.
    J Virol. 1985 Dec;56(3):904-11 PMID: 2999443
  46. Database of homology-derived protein structures and the structural meaning of sequence alignment.
    Proteins. 1991;9(1):56-68 PMID: 2017436
  47. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae.
    Arch Virol. 2003 Nov;148(11):2207-35 PMID: 14579179
  48. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.
    Science. 2005 Jun 10;308(5728):1643-5 PMID: 15831716
  49. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
    J Virol. 1996 Aug;70(8):5487-94 PMID: 8764060
  50. Host cell proteases controlling virus pathogenicity.
    Trends Microbiol. 1994 Feb;2(2):39-43 PMID: 8162439
  51. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
    J Biol Chem. 2004 Nov 19;279(47):49414-9 PMID: 15345712
  52. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.
    Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5 PMID: 15010527
  53. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    J Gen Virol. 2005 Aug;86(Pt 8):2269-2274 PMID: 16033974
  54. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    J Virol. 1994 Sep;68(9):5411-22 PMID: 8057423
  55. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion.
    J Virol. 2004 Jun;78(11):6048-54 PMID: 15141003
  56. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.
    Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5 PMID: 16169905
  57. Structural and functional analysis of the S proteins of two human coronavirus OC43 strains adapted to growth in different cells.
    Arch Virol. 1996;141(6):1123-31 PMID: 8712929
  58. The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.
    J Virol. 1997 Dec;71(12):9427-33 PMID: 9371603
  59. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
    Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7 PMID: 16116101
  60. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.
    Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6 PMID: 15096611
  61. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Annu Rev Biochem. 2000;69:531-69 PMID: 10966468
  62. Requirement of proteolytic cleavage of the murine coronavirus MHV-2 spike protein for fusion activity.
    Adv Exp Med Biol. 1998;440:89-93 PMID: 9782269
  63. Prevention of HIV infection by passive immunization with HIV immunoglobulin.
    AIDS Res Hum Retroviruses. 1991 Dec;7(12):971-3 PMID: 1812946
  64. Ribonuclease S-peptide as a carrier in fusion proteins.
    Protein Sci. 1993 Mar;2(3):348-56 PMID: 8453373
  65. Bats are natural reservoirs of SARS-like coronaviruses.
    Science. 2005 Oct 28;310(5748):676-9 PMID: 16195424
  66. Coronavirus as a possible cause of severe acute respiratory syndrome.
    Lancet. 2003 Apr 19;361(9366):1319-25 PMID: 12711465
Article Info
Journal
Virology
Abbr.
Virology
ISSN
0042-6822
Published
2006-07-05
Epub
2006-00-07
Pages
358-69
Language
English
Region
United States
NLM ID
0110674
PMCID
PMC7111780
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com